Stock Events

Stock Events

Inhibikase Therapeutics (IKT) Q1 2025 Earnings

26MarConfirmed

Q2 2024

Q3 2024

Q4 2024

Q1 2025

-0.79

-0.23

0.32

0.88

Details

Expected EPS

-0.086667

Actual EPS

0.88

Surprise EPS

0.97

Surprise Percent

+1,115.38%

Description

Inhibikase Therapeutics (IKT) has reported earnings of 0.88 per share for Q1 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.